Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player


AstraZeneca CEO quits as sales slump Add to ...

AstraZeneca chief executive David Brennan will step down on June 1 in an abrupt exit after six years in the top job, following rising investor discontent at the company's performance.



In the know

More from The Globe and Mail

Most Popular Stories